The polymorphism of LEPR 3057G > A (rs1805096) probably contributes to the onset of NAFLD by regulating lipid metabolism and affecting insulin sensitivity [22]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.